The Placenta as a Functional Barrier to Fetal Drug Exposure

The Placenta: From Development to Disease

Volumn , Issue , 2011, Pages 303-309

  Nanovskaya, Tatiana N ^a   Hankins, Gary D V ^a   Ahmed, Mahmoud S ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

"kick the habit"; "permeability barrier"; Breast Cancer Resistance Protein (BCRP); Inside out vesicles (IOV); Neonatal abstinence syndrome (NAS); Nicotine addiction; Nicotine replacement therapy (NRTs); Opiate dependence and addiction; Single nucleotide polymorphisms (SNPs)

Indexed keywords

EID: 84885540192     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444393927.ch39     Document Type: Chapter

References (16)

1. Sesardic D, PasanenM, Pelkonen O et al. (1990) Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues. Carcinogenesis 11(7): 1183-8.
2. Manchester DK and Jacoby EH (1981) Sensitivity of human placentalmonooxygenase activity to maternal smoking. Clin Pharmacol Ther 30(5): 687-92.
3. Hieronymus TL,NanovskayaTN,DeshmukhSVet al. (2006) Methadone metabolism by early gestational age placentas. Am J Perinatol 23(5): 287-94.
4. Hemauer SJ,Patrikeeva SL,NanovskayaTNet al. (2009) Opiates inhibit paclitaxel uptake by P-glycoprotein in preparations of human placental inside-out vesicles. Biochem Pharmacol 78(9): 1272-8.
5. Deshmukh SV, Nanovskaya TN, Ahmed MS (2003) Aromatase is the major enzyme metabolizing buprenorphine in human placenta. J Pharmacol Exp Ther 306(3): 1099-105.
6. Nanovskaya TN, Deshmukh SV, Brooks M et al. (2002) Transplacental transfer and metabolism of Buprenorphine. Pharmacology 300(1): 26-33.
7. Nanovskaya TN, Deshmukh SV, Nekhaeva IA et al. (2004) Methadone metabolism by human placenta. Biochem Pharmacol 68: 583-91.
8. Zharikova OL, Ravindran S, Nanovskaya TN et al. (2007) Kinetics of glyburide metabolism by hepatic and placental microsomes of humans and baboon. BiochemPharmacol 73: 2012-19.
9. Facchinetti F, Comitini G, Petraglia F et al. (1986) Reduced estriol and dehydroepianrosterone sulphate plasma levels in methadone-addicted pregnant women. Eur J Obstet Gynecol Reprod Biol 23: 67-73.
10. Wisborg K, Henriksen TB, Jespersen LB et al. (2000) Nicotine patches for pregnant smokers:a randomized controlled study. Obstet Gynecol 96: 967-71.
11. Dempsey DA and Benowitz NL (2001) Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf 24(4): 277-322. Review
12. Rore C, Brace V, Danielian P et al. (2008) Smoking cessation in pregnancy. Expert Opin Drug Saf 7(6): 727- 37.
13. Earhart AD, Patrikeeva S, Wang X et al. (2010) Transplacental transfer andmetabolism of bupropion. JMatern Fetal Neonatal Med 23(5): 409-16.
14. Wang X, Abdelrahman DR, Zharikova OL et al. (2010) Bupropion metabolism by human placenta. Biochem Pharmacol 79(11): 1684-90.
15. Zharikova OL, Fokina VM, Nanovskaya TN et al. (2009) Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide. Biochem Pharmacol 78(12): 1483-90.
16. Yan R, Nanovskaya TN, Zharikova OL et al. (2008) Metabolism of 17alpha-hydroxyprogesterone caproate by hepatic and placental microsomes of human and baboons. Biochem Pharmacol 75(9): 1848- 57.